Dr. Suga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
975 Sereno Dr
Vallejo, CA 94589Phone+1 707-651-1077
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2010
Brown UniversityResidency, Internal Medicine, 2004 - 2007
Tufts University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2007 - 2026
RI State Medical License 2005 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy Start of enrollment: 2009 May 01
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 94 citationsNivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) StudyNilofer S. Azad, Robert Gray, Michael J. Overman, Jonathan D. Schoenfeld, Edith P. Mitchell
Journal of Clinical Oncology. 2020-01-20 - 669 citationsAdjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast CancerAndrew Tutt, Judy Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli
The New England Journal of Medicine. 2021-06-03 - 2 citationsImproving Time to Molecular Testing Results in Patients With Newly Diagnosed, Metastatic Non-Small-Cell Lung Cancer.Stephanie Ossowski, Elad Neeman, Charles Borden, Douglas Stram, Lucy Giraldo
JCO Oncology Practice. 2022-11-01
Press Mentions
Major Financial Hardship Common After Cancer Diagnosis, Despite InsuranceJanuary 4th, 2022- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
